Shanghai Kaibao Pharmaceutical CO.,Ltd held its 1st Extraordinary General Meeting of 2023 on 22 December 2023, during which the following proposal(s) was/were approved: Election and nomination of non-independent directors, cumulative voting system applicable, Mu Jingwei, non-independent director: Zhou Yingbin, non-independent director, Jing Shuzhong, non-independent director, Liu Jianzhong, non-independent director, Ren Liwang, non-independent director, Zhao Ningbo, non-independent director. Election and nomination of independent directors, cumulative voting system applicable: Ye Zuguang, independent director, Li Zhenni, independent director, Ma Hong, independent director.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
6.03 CNY | +0.17% | +4.69% | -9.32% |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-9.32% | 870M | |
+25.83% | 661B | |
+27.00% | 566B | |
-6.76% | 352B | |
+20.34% | 332B | |
+3.00% | 283B | |
+13.09% | 231B | |
+5.46% | 200B | |
-9.61% | 195B | |
-6.26% | 145B |
- Stock Market
- Equities
- 300039 Stock
- News Shanghai Kaibao Pharmaceutical CO.,Ltd
- Shanghai Kaibao Pharmaceutical CO.,Ltd Announces Executive Changes